Discontinued — last reported Q4 '25
Chevron Business Sale Proceeds decreased by 26.9% to $353.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 95.0%, from $7.08B to $353.00M. Over 4 years (FY 2021 to FY 2025), Business Sale Proceeds shows relatively stable performance with a 0.5% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
cf_proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $211.00M | $217.00M | $1.21B | $1.28B | $1.07B | $136.00M | $150.00M | $219.00M | $105.00M | $86.00M | $259.00M | $104.00M | $114.00M | $402.00M | $7.08B | $600.00M | $390.00M | $483.00M | $353.00M |
| QoQ Change | — | +2.8% | +455.3% | +6.5% | -16.9% | -87.2% | +10.3% | +46.0% | -52.1% | -18.1% | +201.2% | -59.8% | +9.6% | +252.6% | >999% | -91.5% | -35.0% | +23.8% | -26.9% |
| YoY Change | — | — | — | — | +405.2% | -37.3% | -87.6% | -82.9% | -90.2% | -36.8% | +72.7% | -52.5% | +8.6% | +367.4% | >999% | +476.9% | +242.1% | +20.1% | -95.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.